Background: Oral isotretinoin (ISO) is the standard of care for severe inflammatory acne and
a threshold dose of 120-150 mg/kg is widely regarded as increasing remission potential …

Background: The correct therapeutic management of acne should include a maintenance
therapy with topical retinoids to prevent recurrences after discontinuing a successful …

Protocols for treating acne with isotretinoin have varied widely because some factors
associated with relapse and treatment duration have not yet been fully determined. This …

Trądzik zwyczajny, pospolity (acne vulgaris) jest najczęstszą chorobą skóry. Z uwagi na
coraz większą liczbę możliwości terapeutycznych podjęliśmy próbę usystematyzowania …

Objective: This study was conducted to compare the effect of low-dose isotretinoin with its
conventional dose in patients with moderate and severe acne. Methods: This was a clinical …

The study aimed to verify the therapeutic action of isotretinoin in the treatment of sebaceous
hyperplasia. During two months, 20 patients with sebaceous hyperplasia took isotretinoin at …

The burden of disease associated with acne vulgaris has continued to increase over time in
the world population. This continued growth suggests that there is an unmet dermatologic …

Purpose: Isotretinoin is the most effective anti-acne drug with a long-term remission.
However; it contains severe teratogenic effects with serious adverse drug reactions, which …

Trądzik zwyczajny jest jedną z najczęstszych i traumatyzujących chorób skóry. Dotyczy 80–
100% osób pomiędzy 11. a 30. rokiem życia, z czego u 85% ma łagodny przebieg …

Objective. To determine the effectiveness and safety of the drug Sotret when treating
patients with severe or moderate acne resistant to other therapies. Material and methods …